Trichotillomania (TTM) is an impulse control disorder characterised by the repeated urge to pull out scalp hair, eyelashes, nose hair, ear hair, eyebrows or other body hair. It is believed to be related to obsessive-compulsive disorder.
Trichotillomania is hair loss caused by compulsive pulling and/or twisting of the hair until it breaks off. The hair may be lost in round patches or diffusely across the scalp. The effect is an uneven appearance. Other hairy areas may be plucked, such as the eyebrows, eyelashes, or body hair.
Genistein, a major component of soy, was found to disrupt the development of the ovaries in newborn female mice that were given the product. This study adds to a growing body of literature demonstrating the potentially adverse consequences of genistein on the reproductive system.
The neurofibromatoses (NF1, NF2 and Schwannomatosis) are a set of distinct genetic disorders. Individuals with NF1 are prone to the development of benign tumors that grow on the nerves anywhere on or in the body. NF1 can also affect other tissues, including the bones, skin, blood vessels, and eyes. In addition, nearly 50% of all people with NF1 have learning disabilities.
Sj?gren’s syndrome is an inflammatory disease that can affect many different parts of the body, but most often affects the tear and saliva glands. Patients with this condition may notice irritation, a gritty feeling, or painful burning in the eyes.
Lupus is caused by Natural Killer (NK) CD4– and CD8– T-Lymphocytes, also called T cells. These T cells multiply using a potassium gene channel. These same cells cause Diabetes.
Berean Development, Inc has developed and is marketing a product that is knocking out a previously thought incurable disease that strikes mainly women – Systemic Lupus Erthematosus to name one of just a few.
Carrots, broccoli, papaya and fruit, this is what helps you to stay young. Many people equate vitamin A with better vision. But our skin’s health is directly dependent on the amount of vitamin A in our diet.
Among breast cancer patients who have undergone mastectomy, adjuvant radiation therapy improves survival. However, there is only a survival benefit when the dose is appropriate and the target area is sufficient. These results were published in the Journal of the National Cancer Institute.
A comparison of two clinical trials suggests that the chemotherapy drug cisplatin is more effective against metastatic osteosarcoma than the chemotherapy drug carboplatin. These results were published in the journal Cancer.